Details of the Drug

General Information of Drug (ID: DMMU5CE)

• Drug Name: Dialyzable leukocyte cells
• Synonyms: Dialyzable leukocyte

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: D01HQJ

References

• [1] ClinicalTrials.gov (NCT04379479) Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T). U.S. National Institutes of Health.